A case of community-acquired MRSA (CA-MRSA) sepsis complicated by meningoencephalitis and cerebral abscess, successfully treated with linezolid;Un caso di sepsi da MRSA comunitario (CA-MRSA) complicata da meningoencefalite ed ascesso cerebrale trattato con successo con linezolid

Infezioni in Medicina

Volumn 17, Issue 4, 2009, Pages 244-248

  Gattuso, Gianni ^a   Palvarini, Loredana ^a   Tomasoni, Donatella ^a   Ferri, Ferdinando ^a   Scalzini, Alfredo ^a  

^a CARLO POMA HOSPITAL   (Italy)

Author keywords

CA MRSA; MRSA; Panton Valentine leukocidin; Staphylococcus aureus

Indexed keywords

AMPICILLIN; CEFTRIAXONE; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ADULT; BRAIN ABSCESS; CASE REPORT; DISEASE ASSOCIATION; FEMALE; HUMAN; MENINGOENCEPHALITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; SEPSIS; TREATMENT OUTCOME; ARTICLE; COMMUNICABLE DISEASE; COMPARATIVE STUDY; FOLLOW UP; ISOLATION AND PURIFICATION; STAPHYLOCOCCUS INFECTION; TIME;

ACETAMIDES; ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BRAIN ABSCESS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENINGOENCEPHALITIS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OXAZOLIDINONES; SEPSIS; STAPHYLOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649250999     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36: 53-59, 2003.
2. Cosgrove S.E., Qi Y., Kaye K.S., Harbarth S., Karchmer A.W., Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay and hospital charges. Infect. Control Hosp. Epidemiol. 26: 166-174, 2005.
3. Daum R.S. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N. Engl. J. Med. 357: 380-390, 2007.
4. Hota B., Ellenbogen C., Hayden M.K. Aroutcheva A., Rice T.W., Weinstein R.A. Community-associated methicillin-resistant Staphylococcus aureus. skin and soft tissue infections at a public hospital. Arch. Intern. Med. 167: 1026-1033, 2007.
5. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR 56: 325-329, 2007.
6. Tinelli M., Pantosti A., Lusardi C. Vimercati M., Monaco M. First detected case of community-acquired methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in Italy. Euro Surveill. 12 (4), E 070412.1, 2007.
7. Pan A., Battisti A., Zoncada A. et al. Community-acquired methicillin-resistant Staphylococcus aureus ST398 infection, Italy. Emerg. Infect. Dis. 15 (5): 845-847, 2009.
8. Giannella M., Monaco M., Nicosia R. Chiarini F., Pantosti A., Venditti M. A dialysis patient with bacteremia caused by a CA-MRSA carrying the staphylococcal chromosome cassette (SCC) mec type V. J. Chemother. 20 (3): 402-404, 2008.
9. Valentini P., Parisi G., Monaco M. et al. An uncommon presentation for a severe invasive infection due to methicillin-resistant Staphylococcus aureus clone USA300 in Italy: a case report. Ann. Clin. Microbiol. Antimicrob. 7: 11, 2008.
10. Tinelli M., Monaco M., Vimercati M., Ceraminiello A., Pantosti A. Methicillin-susceptible Staphylococcus aureus in skin and soft tissue infections, Northern Italy. Emerg. Infect. Dis. 15 (2): 250-257, 2009.
11. Stranden A.M., Frei R., Adler H. Flückiger U., Widmer A.F. Emergence of SCCmec IV as the most common type of Methicillin-resistant Staphylococcus aureus in a university hospital. Infection 37: 44-48, 2009.
12. Nathwani D., Morgan M., Masterton R.G. et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J. Antimicrob. Chemother. 61: 976-994, 2008.
13. Villani P., Regazzi M.B., Viale P. et al. Cerebrospinal fluid linezolid concentrations in postneurosurgical CNS infections. Antimicrob. Agents Chemother. 46 (3): 936-937, 2002.
14. Beer R., Engelhardt K.W., Pfausler B. et al. Pharmacokinetics of Intravenous Linezolid in Cerebrospinal Fluid and Plasma in Neurointensive Care Patients with Staphylococcal Ventriculitis Associated with External Ventricular Drains. Antimicrob. Agents Chemother. 51 (1): 379-382, 2007.
15. Ntziora F., Falagas M. Linezolid for the treatment of patients with CNS infections. Ann. Pharmacother. 41 (2): 296-308, 2007.
16. Pistella E., Campanile F., Venditti M. et al. Successful treatment of disseminated cerebritis complicating methicillin-resistant Staphylococcus aureus endocarditis unresponsive to vancomycin therapy with linezolid. Scand. J. Infect. Dis. 36 (3): 222-225, 2004.
17. Manfredi R., Sabbatani S., Nanetti A., Chiodo F. A puzzling microbiological and clinical discrepancy in the management of acute, severe skin-soft tissue and joint staphylococcal infection. In vitro antimicrobial susceptibility to glycopeptides, versus in vivo clinical efficacy of linezolid alone. Infez. Med. 157 (3): 157-164, 2006.